9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009 Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-09 Conventional Influenza Vaccine Vaccine. 2009 Aug 4.Epub ahead of print
2. 2009 Exploring the Immunome: A Brave New World for Human Vaccine Development. Human Vaccines. Human Vaccines 5:12, 1-4; December 2009;
3. 2009 Immunome-derived Epitope-driven Vaccines (ID-EDV), Protect against Viral or Bacterial Challenge in Humanized Mice July 2009. Procedia in Vaccinology Volume 1, Issue 1, 2009, Pages 15-22
4. 2009 T cell epitope: Friend or Foe? Immunogenicity of biologics in context. Advanced Drug Delivery Reviews. Volume 61 (11), 30 September 2009; 965-976
5. 2009 Can we prevent the immunogenicity of Protein Drugs. Annals of Rheumatology. Accepted, in press 2009.
6. 2009 Immunome Derived Vaccines: The Next Step in Vaccine Design Springer, 2009 (in press).
7. 2009 Tools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-driven Vaccines John Wiley and Sons
8. 2009 Reducing Risk, Improving Outcomes: Bioengineering less immunogenic protein therapeutics Clin Immunol. 2009 May;131(2):189-201
9. 2009 In Silico-Accelerated Identification of Conserved and Immunogenic Variola/Vaccinia T-Cell Epitopes Submitted to Vaccine (David Weiner, special editor), Published Vaccine.
10. 2009 AS.Epitope-based vaccination against pneumonic tularemia Vaccine. 2009 Aug 27;27(39):5299-306. Epub 2009 Jul 17
11. 2008 Epitope-based Immunome-derived Vaccines: A Strategy for Improved Design and Safety Springer Immunomics Series. Editor Andras Falus. Falus, Andras (Ed.) 2009.
12. 2008 A place to be healthy: blueprint for a new free clinic for the medically uninsured of Rhode Island Med Health R I. 2008 Apr;91(4):105-8.
13. 2008 Prediction of Immunogenicity: In Silico Paradigms, Ex Vivo and In Vivo Correlates Curr Opin Pharmacol. 2008 Oct;8(5):620-6
14. 2008 The Sir Mark Oliphant conferences: International frontiers of science and technology. Belz GT, De Groot A. Hum Vaccin. 2008 Jul-Aug;4(4):260-1.
15. 2008 The measles campaign in West and Central Africa: Remembering the future Vaccine Vol 26/31 pp 3783-3786, 2008. DOI: 10.1016/j.vaccine.2008.04.088.
16. 2008 Immunogenicity screening using in silico methods: Correlation between T-cell epitope content and clinical immunogenicity of monoclonal antibodies New York: John Wiley and Sons; October 2009
17. 2008 Mycobacterium Tuberculosis Vaccines. Elsevier (Accepted December 2007. Published December, 2008).
18. 2008 Activation of Natural Regulatory T cells by IgG Fc-derived Peptide Tregitopes. Blood, 2008,112: 3303
19. 2008 Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules Leukemia, 2008, Feb;22(2):424-6
20. 2008 Identification of Immunogenic HLA-B7 Achilles heel Epitopes Within Highly Conserved Regions of HIV Vaccine, 2008 26, 3059—3071.
21. 2008 Novel function of complement C3d as an autologous helper T-cell target. Immunol Cell Biol. 2008 Mar;86(3):221-5.
22. 2008 A call to cellular & humoral arms: Enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A Hum Vaccin. 2008 Mar-Apr;4(2):148-57.
23. 2007 Evolutionary deimmunization: An ancillary mechanism for self-tolerance. Cell Immunol. 2007 Apr 17; Epub. Cellular Immunology. Volume 244, Issue 2, December 2006, Pages 148-153. http://dx.doi.org/10.1016/j.cellimm.2007.02.006
24. 2007 Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. The Pharmacogenomics Journal, 15 May 2007; doi:10.1038/sj.tpj.6500458.
25. 2007 Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion J Clin Immunol. 2007 Nov;27(6):620-7. Epub 2007 Jul 14.
26. 2007 A Vaccine Renaissance From Basic Research to Implementation Medicine and Health, Rhode Island. October 2007. Oct, 90(10):300.
27. 2007 Tularemia Vaccines An Overview. Medicine and Health, Rhode Island. October 2007. Oct, 90(10):311-317.
28. 2007 HIV testing in prisons and jails--providing the carrot with the stick. AIDS Read. 2007 Sep;17(9):463
29. 2007 Progress Towards a Genome-derived, Epitope-driven Vaccine for Latent TB Infection. Oct, 90(10):301-303.
30. 2007 Immunogenicity of Protein Therapeutics Trends in Immunology. Invited Review. Trends Immunol. 2007 Nov;28(11):482-90.
31. 2007 Prediction of immunogenicity for therapeutic proteins: State of the art. Current Opinions in Drug Development and Discovery. May 2007. 10(3):332-40.
32. 2007 Immunoinformatics applied to modifying and improving biological therapeutics. Kluwer publications Immunoinformatics. Series: Immunomics Reviews: Vol. 1. Schönbach, Christian; Ranganathan, Shoba; Brusic, Vladimir (Eds.) 2007, ISBN: 978-0-387-72967-1. Available: September 21, 2007.
33. 2007 New tools, new approaches and new ideas for vaccine development. Expert Rev Vaccines. 2007 Apr; 6 (2):125-7.
34. 2007 A Letter From a Prison Doctor, In Correctional Perspectives. Views from Academics, Practitioners, and Prisoners Oxford University Press. Apr 2007.
35. 2007 Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria Mol Genet Metab. 2007 Aug;91(4):325-34. Epub 2007 Jun 8.
36. 2007 Epitope-Driven TB Vaccine Development : A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice Current Molecular Medicine, Curr Mol Med. 2007 Jun;7(4):351-68.
37. 2007 Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: Identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine. 2007 Apr 20;25(16):3179-91.
38. 2007 Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein Clin Immunol. 2007 Jul;124(1):26-32.
39. 2007 Analysis of ChimeriVax Japanese Encephalitis(JE) virus Sequence for T cell epitopes and comparison to circulating wild type JE Virus strains Nov. 2007. Vaccine 25 (2007) 8077–8084.
40. 2007 Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori Hum Vaccines. 2007 Dec 8;4(3).
41. 2006 Putting immunoinformatics to the test. Nature Biotechnology. Volume 24 (7) July 2006
42. 2006 Immunomics: discovering new targets for vaccines and therapeutics. Drug Discovery Today. 2006 Mar;11 (5-6):203-9.
43. 2006 Confirmation of Immunogenic Consensus Sequence HIV-1 T-cell Epitopes in Bamako, Mali and Providence, Rhode Island. Human Vaccines 2006 June; 2(3), 119-128
44. 2006 Living up to Our Commitments: An assessment of the United States response to its domestic HIV/AIDS epidemic Open Society Institute Public Health Watch HIV/AIDS Project. May 2006.
45. 2006 Challenges and Opportunities for HIV Care in Jails and Prisons in the United States International Journal of Prisoner Health, September 2006; 2(3): 173-191.
46. 2006 Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding Infect Immun. 2007 Feb;75(2):915-23. Epub 2006 Nov 6.
47. 2006 Putting immunoinformatics to the test Nature Biotechnology, 2006; 24(7): 791-92
48. 2005 De-immunization of therapeutic proteins by T cell epitope modification Dev. Biol. Basel, Karger, 2005. Vol 122. pp 137-160.
49. 2005 HIV Infection in Incarcerated Women Rutgers University Press
50. 2005 Hepatitis B and hepatitis C among offenders within prisons. Civic Research Institute
51. 2005 Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine. 2005 Aug 30.
52. 2005 TB Vaccine Development: Opportunity and Imperative Editor. Horizon Scientific Press Ltd. 2005.
53. 2005 Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J Clin Endocrinol Metab. 2006 Jun;91(6):2286-94. Epub 2006 Apr 4.
54. 2005 HIV vaccine development by computer assisted design: the GAIA vaccine Vaccine. 2005 Mar 18; 23 [7-18):2136-48.
55. 2005 Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine. 2005 Mar 18; 23(17-18):2121-31.
56. 2005 Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes Tuberculosis (Edinb). 2005; 85(1-2):95-105.
57. 2004 Immunome Derived Vaccines Expert Opin Biol Ther. Jun; 4(6):767-772, 2004.
58. 2004 Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods. 2004 Dec; 34(4):476-87 Bioinformatics in Vaccine Design.
59. 2004 From Genome to Vaccine – New Immunoinformatics tools for vaccine design. Bioinformatics for Vaccine Design. Volume 34, Issue 4, December 2004, Pages 425-428.
60. 2004 From immunome to vaccine: epitope mapping and vaccine design tools. Novartis Foundation Symposium No.254. 2004.
61. 2004 High throughput informatics and in vitro assays for T cell epitope determination: Application to the design of epitope-driven vaccines Marcel Dekker Inc. NYC, NY
62. 2004 HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase Infect Immun. 2004 Apr; 72(4):2412-5.
63. 2004 Genome-derived vaccines. Expert Rev Vaccines. 2004. Feb; 3(1):59-76.
64. 2003 How the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past Vaccine 21 (2003) 4095–4104
65. 2003 Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B Infect Immun. 2003 Mar; 71 (3):1179-84
66. 2003 Smallpox vaccination – Time for a Novel Approach? Vaccine and Technology Development News, Vol 2 (8). November /December 2003.
67. 2003 Mapping Cross-clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach Vaccine 21 (2003) 4486–4504.
68. 2003 Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection J Immunol. 2003 Jul 1; 171(1):307-16.
69. 2003 T Cell Epitope Identification for Bovine Vaccines: An Epitope Mapping Method for BoLA A-11 International Journal for Parasitology (Thematic Issue on Vaccines, David Brake Editor, (Vol 33/5-6 pp 641-653). 2003.
70. 2003 The use of bioinformatics for identifying class I restricted T cell epitopes Methods (Epitope Mapping Issue). Bill Kwok, editor, Methods 29 (2003) 289–298.
71. 2003 Modeling the immunogenicity of therapeutic proteins using T cell epitope mapping. editors. Basel, Karger, 2003. Vol 112:71-80.
72. 2002 Learning From the Past, Planning for the Future—DOT for HIV Infection. The AIDS Reader. 2002 Jul; 12(7):314-5
73. 2002 Immuno-informatics: Mining the genome for Vaccine Components Immunology and Cell Biology. Immunology and Cell Biology (2002) 80, 255–269.
74. 2002 Women in Prison. A Standard of HIV Care Published by the National Commission on Correctional Health Care.
75. 2002 Use of bioinformatics to predict MHC ligands and T-cell epitopes: Application to vaccine design Edited by Stefan Kaufmann and Dieter Kabelitz,
76. 2002 HLA-B*35-Restricted CD8+-T-Cell Epitope in Mycobacterium tuberculosis Rv2903c Infection and Immunity, February 2002, p. 981-984, Vol. 70, No. 2
77. 2001 An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1 infected Thais AIDS Research and Human Retroviruses 2001; 17(8):703-18.
78. 2001 Designing HIV-1 vaccines to reflect viral diversity and the global context of HIV/AIDS. AIDScience 1(2) June 22, 2001
79. 2001 Alarming statistics about incarcerated women Posit Aware. 2001 Jul-Aug; 12(4):19-21.
80. 2001 Women incest survivors in prison Posit Aware. 2001 Jul-Aug; 12(4):27-9.
81. 2001 Rapid Determination of HLA B*07- ligands from the West Nile Virus genome Emerging Infectious Diseases, Vol. 7, No. 4, July–August 2001: 706-713.
82. 2001 From genome to vaccine: In silico predictions, ex vivo verification. Vaccine 2001 Aug 14; 19(31):4385-95
83. 2001 HIV Clinical Trials in Correctional Settings: Right or Retrogression? AIDS Reader. 2001; 11(1):34-40.
84. 2001 Use of T cell epitopes for vaccine development Current Drug Targets - Infectious Disorders, 2001, 1, 283-293.
85. 2000 A Postgenomic Approach to Identification of Mycobacterium leprae-Specific Peptides as T-Cell Reagents Infection and Immunity, October 2000, p. 5846-5855, Vol. 68, No. 10
86. 2000 HIV infection among incarcerated women: Epidemic behind bars. AIDS Reader, 2000; 10:287-295.
87. 2000 Shedding light on correctional HIV care. AIDS Reader 2000; 10:285-286.
88. 2000 Clinical Trials in Correctional Settings: Proceedings of a conference held in Providence Rhode Island Journal of Medicine, 83; (12) December 2000, pp 376-379.
89. 2000 Women Prisoners with HIV: An Open Letter from a Prison Doctor Roxbury Publishing Company
90. 2000 UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) 9-11 February 2000, Geneva, Switzerland
91. 2000 Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm. AIDS Res Hu Retroviruses Vol 16, No.1, pp. 67-76, January 2000.
92. 2000 Thyroglobulin as Autoantigen: Structure–Function Relationships. Reviews in Endocrine & Metabolic Disorders. Kluwer Academic, NY. Volume 1, Numbers 1-2, February 2000, Pages: 69 – 77
93. 1999 Legacy of light for women living with HIV in prison Lancet, March 27 1999. 353. pp 1107, March 1999.
94. 1999 In Silico Predictions; in Vivo Veritas Nature Biotechnology Vol 17, No. 6, pp. 533-34, June 1999.
95. 1999 T Cell Recognition of Hypervariable Region-1 from Hepatitis C Virus Envelope Protein with Multiple Class II MHC Molecules in Mice and Humans: Preferential Help for Induction of Antibodies to the Hypervariable Region The Journal of Immunology, 1999, 162: 568-576.
96. 1999 Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis. 1999 Mar; 179 (3):637-45.
97. 1998 Reports from the New England Regional Symposium on HIV Infection among incarcerated women J. Correctional Health Care, 1998, Vol. 5, Issue 2, pp. 125-127.
98. 1998 Setting the Standard for Care: HIV Risk Exposures and Clinical Manifestations of HIV in Incarcerated Massachusetts Women New England Journal of Criminal and Civil Confinement, Vol 24, pp 353-378, July 1998.
99. 1998 The need for Compassionate Care: HIV Infection Among Incarcerated Women Medicine and Health, RI, Vol 81. No. 6, p 209-211, 1998
100. 1998 Prediction and determination of MHC ligands and T Cell Epitopes, Chapter 3, Immunology Methods, SHE Kaufmann, ed, Methods in Microbiology Vol 25, p 79-106, Academic Press, NY 1998.
101. 1998 A Standard of HIV care for incarcerated women: Northeastern United States' Experiences J. Correctional Health Care, 1998, Vol. 5, Issue 2, pp. 139-177.
102. 1998 Critical prevention, critical care: gynecological and obstetrical aspects of comprehensive HIV prevention and treatment among incarcerated women J. Correctional Health Care, 1998, Vol. 5, Issue 2, pp.201-223
103. 1998 Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix Vaccine, 1998, Vol. 16, No. 19, pp. 1880-1884.
104. 1998 Molecular Epidemiology of HIV-1 Infection in the Philippines, 1985-1997: Transmission of Subtypes B and E and Potential Emergence of Subtypes C and F J. AIDS and Hu Retrovirology, 1998, Vol. 18, No. 3, pp. 260-269.
105. 1998 Co-Infection with M. tuberculosis (Mtb) and HIV in high risk clinical care settings in Rhode Island AIDS Care, 1998, Vol. 10, No. 2, pp. 221-229
106. 1997 Cloning and characterization of murine thyroglobulin cDNA. Clin Immunol Immunopathol. 1997 Nov;85(2):221-6.
107. 1997 Differential immune responses against a Schistosoma mansoni candidate vaccine antigen in three murine strains. Vaccines 97, 1997, 213-217.
108. 1997 Put her in a cage: Childhood sexual abuse, incarceration, and HIV infection New York University Press
109. 1997 An interactive Web site providing major histocompatibility ligand predictions: application to HIV research AIDS Res Hum Retroviruses. 1997 May 1; 13(7):529-31.
110. 1997 Matrix-based prediction of MHC-binding peptides: the Epimatrix algorithm, reagent for HIV research Vaccines 97, pp. 57-64, Cold Spring Harbor Laboratory Press 1997.
111. 1997 The role of peptides in the recognition of HLA-B27 by cytotoxic T cells and by antibodies, with special emphasis on arthritis patients Landes Bioscience, Austin Texas USA.1997.
112. 1996 Prediction of HIV peptide epitopes by a novel algorithm AIDS Research and Human Retroviruses, 1996, Vol. 12, No. 7, pp. 593-610.
113. 1996 A novel algorithm for the efficient identification of T cell epitopes: prediction and testing of candidate TB vaccine peptides in genetically diverse populations Vaccines 96, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 127-134.
114. 1996 Computer Prediction of T Cell Epitopes Marcel Dekker Inc. NYC
115. 1995 Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences Vaccine 1995, Vol. 13, No. 6, pp. 581-591.
116. 1995 Risks for HIV infection in incarcerated women J. Women's Health, 1995, Vol. 4, No. 5, pp. 569-577
117. 1995 The Rhode Island Prison Release Program Health Resources Development Office of Science and Epidemiology, June 1995.
118. 1995 Algorithms for Mycobacterial Vaccine Development USDA/NIAID, NIH, 1995.
119. 1995 Prediction of T Cell Epitopes for HIV vaccine development by computer-driven algorithm New Mexico, pp. iv17-iv28.
120. 1995 Prevalence of prior sexual abuse and HIV risk-taking behaviors in incarcerated women in Massachusetts J. Correctional Health Care, 1995, Vol. 2, Issue 2, pp. 137-149.
121. 1993 , T-cell responses to Mycobacterium tuberculosis antigens in the HIV-infected host. Vaccines 93, Cold Spring Harbor Press, Cold Spring Harbor, NY, pp. 251-257.
122. 1992 Medical Care of HIV-Infected Prisoners: The Rhode Island Experience PRIM&R Conference Proceedings Oct 29-30, 1992
123. 1991 Human Immunodeficiency Virus Reverse Transcriptase T Helper Epitopes Identified in Mice and Humans: Correlation with a Cytotoxic T Cell Epitope J. Infectious Disease 1991, Vol.164, pp.1058-1065.
124. 1990 Evidence implicating MHC genes in the immunological nonresponsiveness to the plasmodium falciparum CS protein Bulletin of the World Health Organization, 68 Supplement: pp. 80-84, 1990.
125. 1989 Differential nonresponsiveness in humans of candidate Plasmodium falciparum vaccine antigens Am. J. Trop. Med. Hyg., 1989, Vol. 41, Issue 2, pp. 125-134.
126. 1989 Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein J. Immunol., 1989, Vol.142, No.11, pp. 4000-4005.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.